UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036027
Receipt number R000041034
Scientific Title A monitoring study on the real-time sensing of human response (a single-arm intervention study)
Date of disclosure of the study information 2019/03/03
Last modified on 2024/05/21 13:13:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A monitoring study on the real-time sensing of human response (a single-arm intervention study)

Acronym

A monitoring study on the real-time sensing of human response (a single-arm intervention study)

Scientific Title

A monitoring study on the real-time sensing of human response (a single-arm intervention study)

Scientific Title:Acronym

A monitoring study on the real-time sensing of human response (a single-arm intervention study)

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate environmental influences on human.

Basic objectives2

Others

Basic objectives -Others

Research

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Nose temperature, heart rate, acceleration, amount of activity, brain activity, degree of fatigue, sleep quality

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Airflow amount through an air conditioner unit, illuminance in a room, stretching, and meditation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1. Age 20 years and older
2. Males
3. Undergraduate students
4. Those who can sleep at least 6 hours per night on a daily basis as well as during the exam period.
5. Non-smokers
6. Those who can complete the testing schedule.
7. Those who can submit an informed consent document.

Key exclusion criteria

1. Those who are currently receiving treatment for some kind of systemic disease.
2. Those who seem to have difficulty making their own judgements (due to dementia, mental illness, etc.)
3. Those who were determined by the principal investigator to be unsuitable for participation in this study.

Target sample size

4


Research contact person

Name of lead principal investigator

1st name Kazuyoshi
Middle name
Last name Harimoto

Organization

TAISEI Corporation

Division name

Valuable Space Research Section,Urban Engineering Research Department,Technology Center

Zip code

245-0051

Address

344-1,Nase-cho,Totsuka-ku,Yokohama,Japan

TEL

090-9026-7660

Email

kazuyoshi.harimoto@sakura.taisei.co.jp


Public contact

Name of contact person

1st name Kazuyoshi
Middle name
Last name Harimoto

Organization

TAISEI Corporation

Division name

Valuable Space Research Section,Urban Engineering Research Department,Technology Center

Zip code

245-0051

Address

344-1,Nase-cho,Totsuka-ku,Yokohama,Japan

TEL

090-9026-7660

Homepage URL


Email

kazuyoshi.harimoto@sakura.taisei.co.jp


Sponsor or person

Institute

TAISEI Corporation
KANEKA Corporation

Institute

Department

Personal name



Funding Source

Organization

TAISEI Corporation
KANEKA Corporation

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Suda Clinic institutional review board

Address

2-8-14,Takadanobaba,Shinjyuku,Tokyo

Tel

03-6704-5968

Email

jimukyoku@imeqrd.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 04 Day

Date of IRB

2019 Year 02 Month 26 Day

Anticipated trial start date

2019 Year 03 Month 11 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 27 Day

Last modified on

2024 Year 05 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041034